The Vysis LSI ALK Break Apart FISH Probe Kit (Abbott Molecular, Des, Plaines, IL) has become a Food and Drug Administration (FDA)-approved companion diagnostic agent to the ALK inhibitor, crizotinib, in a targeted therapy for lung cancers. Here, ALK is linked to lung cancer.